Research Impact

h-index

N/A

Research impact score

Publications

0

Total publications

Trial Results

0

Published trial results

Citations

0

Total citations

Drug Portfolio

Analytics

Trial Phases

Phase 11
Phase 22

Trial Status

Recruiting1
Terminated1

Role Distribution

Principal Investigator2
PI Rate100%

Activity Timeline

Clinical Trials (2)

NCT04022239Phase 1/2Recruiting
Bendamustine With or Without Cyclophosphamide in Preventing GVHD in Patients Undergoing Stem Cell Transplant
Hematopoietic and Lymphoid System Neoplasm
PrincipalinvestigatorStart date: 2020-03-13
NCT03856216Phase 2Terminated
Inotuzumab Ozogamicin and Chemotherapy in Treating Patients With Leukemia or Lymphoma Undergoing Stem Cell Transplantation
Acute Lymphoblastic LeukemiaB Acute Lymphoblastic LeukemiaLymphocytic Neoplasm+1 more
PrincipalinvestigatorStart date: 2019-10-28

Research Network

Collaboration Network

1 collaborators·0 connections
Network Legend
KOL
Current Investigator
CO
High-influence Collaborator
CO
Collaborator
Click: view details
Double-click: go to profile
Drag: move node

Similar Key Opinion Leaders

Discover other key opinion leaders with similar research profiles, therapeutic areas, and collaboration networks.

10 similar investigators found

Beata Holkova, MD

Massey Cancer Center

Related
3 trials

Shared therapeutic areas:

Precursor Cell Lymphoblastic Leukemia-LymphomaLymphoma

Worked with same sponsors:

National Cancer Institute (NCI)
Similarity Score12%

Brigitte C Widemann, M.D.

National Cancer Institute (NCI)

Related
19 trials

Shared therapeutic areas:

Precursor Cell Lymphoblastic Leukemia-LymphomaLymphoma

Worked with same sponsors:

National Cancer Institute (NCI)
Similarity Score12%

Jorge Cortes, MD

M.D. Anderson Cancer Center

Related
24 trials

Shared therapeutic areas:

Precursor Cell Lymphoblastic Leukemia-LymphomaLymphoma

Worked with same sponsors:

M.D. Anderson Cancer CenterNational Cancer Institute (NCI)
Similarity Score12%

Mary Horowitz, MD

Center for International Blood and Marrow Transplant Research

Related
24 trials

Shared therapeutic areas:

LymphomaPrecursor Cell Lymphoblastic Leukemia-Lymphoma

Worked with same sponsors:

National Cancer Institute (NCI)
Similarity Score12%

Helen Heslop, MD

Baylor College of Medicine

Related
17 trials

Shared therapeutic areas:

Precursor Cell Lymphoblastic Leukemia-LymphomaLymphoma

Worked with same sponsors:

M.D. Anderson Cancer Center
Similarity Score12%

David Avigan, MD

Beth Israel Deaconess Medical Center

Related
17 trials

Shared therapeutic areas:

Precursor Cell Lymphoblastic Leukemia-LymphomaLymphoma

Worked with same sponsors:

National Cancer Institute (NCI)
Similarity Score12%

Gary Schiller, MD

University of California, Los Angeles

Related
3 trials

Shared therapeutic areas:

Lymphoma
Similarity Score6%

Jae Park, MD

Memorial Sloan Kettering Cancer Center

Related
17 trials

Shared therapeutic areas:

Precursor Cell Lymphoblastic Leukemia-Lymphoma

Worked with same sponsors:

National Cancer Institute (NCI)
Similarity Score6%

Corey J. Langer, MD

Fox Chase Cancer Center

Related
16 trials

Shared therapeutic areas:

Lymphoma

Worked with same sponsors:

National Cancer Institute (NCI)
Similarity Score6%

Hagop Youssoufian, MD

Verastem, Inc.

Related
20 trials

Shared therapeutic areas:

Lymphoma
Similarity Score6%

Publications (0)

No publications found for this investigator.

Clinical Trials (2)

Showing 2 of 2 trials

NCT04022239Phase 1/2PrincipalInvestigator

Bendamustine With or Without Cyclophosphamide in Preventing GVHD in Patients Undergoing Stem Cell Transplant

Hematopoietic and Lymphoid System Neoplasm
Recruiting
NCT03856216Phase 2PrincipalInvestigator

Inotuzumab Ozogamicin and Chemotherapy in Treating Patients With Leukemia or Lymphoma Undergoing Stem Cell Transplantation

Acute Lymphoblastic LeukemiaB Acute Lymphoblastic LeukemiaLymphocytic Neoplasm+1 more
Terminated

All 2 trials loaded